Boudewyn A[au] - Search Results

Year	Number of Results
1995	2
1997	1
1998	1
1999	4
2000	1
2001	2
2002	1
2023	0

1

Childhood sexual abuse as a precursor to depression and self-destructive behavior in adulthood.

Boudewyn AC, Liem JH. Boudewyn AC, et al. J Trauma Stress. 1995 Jul;8(3):445-59. doi: 10.1007/BF02102969. J Trauma Stress. 1995. PMID: 7582609

2

Psychological, interpersonal, and behavioral correlates of chronic self-destructiveness: an exploratory study.

Boudewyn AC, Liem JH. Boudewyn AC, et al. Psychol Rep. 1995 Dec;77(3 Pt 2):1283-97. doi: 10.2466/pr0.1995.77.3f.1283. Psychol Rep. 1995. PMID: 8643793

3

The psychosocial impact of multiple sclerosis: exploring the patient's perspective.

Mohr DC, Dick LP, Russo D, Pinn J, Boudewyn AC, Likosky W, Goodkin DE. Mohr DC, et al. Among authors: boudewyn ac. Health Psychol. 1999 Jul;18(4):376-82. doi: 10.1037//0278-6133.18.4.376. Health Psychol. 1999. PMID: 10431939

4

Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.

Mohr DC, Likosky W, Dwyer P, Van Der Wende J, Boudewyn AC, Goodkin DE. Mohr DC, et al. Among authors: boudewyn ac. Arch Neurol. 1999 Oct;56(10):1263-5. doi: 10.1001/archneur.56.10.1263. Arch Neurol. 1999. PMID: 10520943

5

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.

Mohr DC, Goodkin DE, Masuoka L, Dick LP, Russo D, Eckhardt J, Boudewyn AC, Bedell L. Mohr DC, et al. Among authors: boudewyn ac. Mult Scler. 1999 Jun;5(3):192-7. doi: 10.1177/135245859900500309. Mult Scler. 1999. PMID: 10408720 Clinical Trial.

6

Assessing resilience in adults with histories of childhood sexual abuse.

Liem JH, James JB, O'Toole JG, Boudewyn AC. Liem JH, et al. Among authors: boudewyn ac. Am J Orthopsychiatry. 1997 Oct;67(4):594-606. doi: 10.1037/h0080257. Am J Orthopsychiatry. 1997. PMID: 9361866

7

Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications.

Mohr DC, Cox D, Epstein L, Boudewyn A. Mohr DC, et al. Among authors: boudewyn a. J Behav Ther Exp Psychiatry. 2002 Mar;33(1):39-47. doi: 10.1016/s0005-7916(02)00011-3. J Behav Ther Exp Psychiatry. 2002. PMID: 12389798

8

Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a.

Mohr DC, Likosky W, Boudewyn AC, Marietta P, Dwyer P, Van der Wende J, Goodkin DE. Mohr DC, et al. Among authors: boudewyn ac. Mult Scler. 1998 Dec;4(6):487-9. doi: 10.1177/135245859800400605. Mult Scler. 1998. PMID: 9987757

9

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject.

Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Mohr DC, et al. Among authors: boudewyn ac. Ann Behav Med. 2001 Spring;23(2):125-32. doi: 10.1207/S15324796ABM2302_7. Ann Behav Med. 2001. PMID: 11394554

10

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Mohr DC, et al. Among authors: boudewyn ac. J Consult Clin Psychol. 2001 Dec;69(6):942-9. J Consult Clin Psychol. 2001. PMID: 11777121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results